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Abstract
Objective
Hypoxia is known to induce pancreatic beta cell dysfunction and apoptosis. Changes in Pro-
grammed Cell Death Gene 4 (PDCD4) expression have previously been linked with beta
cell neogenesis and function. Our aim was to investigate the effects of hypoxia on cell viabil-
ity, PDCD4 expression and subcellular localisation.
Methods
MIN6 beta cells and ARIP ductal cells were exposed to 1% (hypoxia) or 21% O2 (normoxia)
for 12 or 24 hours. MTT assay, HPI staining, scanning electron microscopy, western blotting
and immunocytochemistry analyses were performed to determine the effect of hypoxia on
cell viability, morphology and PDCD4 expression.
Results
24 hour exposure to hypoxia resulted in ~70% loss of beta cell viability (P<0.001) compared
to normoxia. Both HPI staining and SEM analysis demonstrated beta cell apoptosis and
necrosis after 12 hours exposure to hypoxia. ARIP cells also displayed hypoxia-induced
apoptosis and altered surface morphology after 24 hours, but no significant growth differ-
ence (p>0.05) was observed between hypoxic and normoxic conditions. Significantly higher
expression of PDCD4 was observed in both beta cells (P<0.001) and ductal (P<0.01) cells
under hypoxic conditions compared to controls. PDCD4 expression was localised to the
cytoplasm of both beta cells and ductal cells, with no observed effects of hypoxia, normoxia
or serum free conditions on intracellular shuttling of PDCD4.
Conclusion
These findings indicate that hypoxia-induced expression of PDCD4 is associated with
increased beta cell death and suggests that PDCD4 may be an important factor in regulating
beta cell survival during hypoxic stress.
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Introduction
Hypoxia can occur in many pathological conditions and is defined as an oxygen level 2%.
Ambient air is 21% oxygen; however, most mammalian tissues exist at 2%-9% oxygen [1]. Cel-
lular oxygen tension depends on a balance between oxygen supply and demand, with an
imbalance leading to hypoxia [1, 2]. There have been recent reports on the effect of hypoxia on
pancreatic islets, inducing a reduction in beta cell survival post transplantation, associated
with the low oxygenation of grafted pancreatic islets [3] and resulting in higher numbers of
islets being required to restore glucose homeostasis [4]. It is clear that high vascular density
and oxygenation of transplanted islets is necessary in order to prevent beta cell dysfunction
and apoptosis by hypoxia [5–7].
Beta cell death by apoptosis [8] contributes significantly to both Type 1 Diabetes (T1D) and
Type 2 Diabetes (T2D) [9, 10]; however, the molecular mechanisms behind this are poorly
understood. It has recently been suggested that PDCD4 (programmed cell death protein 4)
and NFκB (nuclear factor kappa B) form a unique regulatory axis that controls programmed
cell death of beta cells [11]. Also, our previous data have shown that PDCD4 plays a crucial
role in beta cell neogenesis and function [12].
Programmed cell death 4 gene (Pdcd4) (also known as MA-3, TIS, H731 and DUG) was
first identified during an investigation into genes up-regulated in the process of apoptosis
[13–16]. Pdcd4 has recently shown to be a novel tumour suppressor gene demonstrating
down-regulation or loss of expression in several types of cancer [17–25]. PDCD4 is ubiqui-
tously expressed in normal tissue and up-regulation of the PDCD4 protein has been identi-
fied in both apoptotic as well as healthy cells [13]. Manipulation of PDCD4 expression by
ectopically over-expressing [26] or knocking down expression [27, 28] have shown signifi-
cant effects on cell growth and survival. How PDCD4 exerts its effect is not known; however,
it has been reported that in the cytoplasm PDCD4 protein interacts with eukaryotic transla-
tion initiation factor 4A (eIF4A) via its MA-3 domain and inhibits its helicase activity, thus
inhibiting cap-dependent translation [29, 30]. In addition, in the nucleus PDCD4 inhibits
transcription factor activator protein-1 (AP-1) activity and controls gene transcription. Thus
cellular localisation of PDCD4 is a potential regulator of its activity but conflicting data exist
about the subcellular localisation of PDCD4. Some studies have found that PDCD4 is local-
ized in the nucleus in normal cells and in the cytoplasm in cancer cells [19,31] whilst others
have reported opposite findings [18]. This conflicting data might be due to the shuttling of
PDCD4 between the cytoplasm and nucleus [32], cell cycle association of PDCD4 localisa-
tion [33] or cell type specific localisation of PDCD4 protein [34]. Subcellular localisation and
expression of PDCD4 protein in pancreatic cells has not, however, been extensively studied
to date.
The aim of this study was to investigate the expression and subcellular localisation of
PDCD4 in MIN6 cells, a mouse pancreatic beta cell line and ARIP, a rat pancreatic ductal cell
line, under both normoxic and hypoxic conditions. We demonstrate here for the first time
that PDCD4 expression is increased under hypoxic conditions, as beta cell viability constantly
decreases. Finally, we show that an increase in cytoplasmic PDCD4 expression is associated
with apoptosis/necrosis in pancreatic beta cells exposed to hypoxia, suggesting that hypoxic
conditions and elevated PDCD4 expression may contribute to beta cell loss in grafted islets
post transplantation. In addition, our findings indicate that PDCD4 is localised to the cyto-
plasm of pancreatic cells and neither hypoxic nor serum starvation conditions are capable of
inducing PDCD4 shuttling.
PDCD4 in hypoxia
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Abbreviations: HPI, Hoechst Propidium iodide;
ICC, immunocytochemistry; PDCD4, Programmed
Cell Death Gene 4; SEM, scanning electron
microscopy; WB, western blotting.
Research design and methods
Materials
DMEM low glucose (Cat No E15-806), DMEM-F12K (Cat No E15-012), foetal calf serum
(FCS)(Cat No A15-104) and trypsin (Cat No L11-659) were purchased from PAA Laborato-
ries, UK.
Antibodies to Programmed Cell Death Gene 4 (PDCD4) (Cat No ab51495), β-actin (Cat
No ab8226), Lamin B1 (Cat No ab8226), HIF1-alpha (Cat No ab51608) and FITC conjugated
anti-rabbit secondary antibodies (Cat No ab6717) were purchased from AbCam, UK. HRP-
conjugated anti-rabbit (Cat No A0545), anti-mouse secondary antibodies (Cat No A5278),
goat serum (Cat No G9023) and all laboratory chemicals and reagents were purchased from
Sigma, UK unless otherwise stated.
Cell culture
The mouse pancreatic β-cell line (Min6) [35] was used between passages 28 to 34 and cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM) with 5mM glucose containing 2mM L-glu-
tamine and supplemented with 10% (V/V) FCS and 100 units/ml penicillin and streptomycin
100μg/ml. The rat pancreatic ductal cell line ARIP (ATCC number: CRL-1674) [36] was used
between passages 18 to 26 and cultured in F-12K medium supplemented with 10% (V/V) FCS,
2mM L-glutamine, 100units/ml penicillin and streptomycin 100μg/ml. In all experiments cells
were serum starved overnight in medium without FCS (to synchronise cells to G0). The fol-
lowing day cells were stimulated with standard culture medium containing 10% FCS and sub-
sequently were exposed to normoxia (21% O2, 5% CO2) or hypoxia (1% O2, 5% CO2) at 37˚C
in a hypoxic chamber (COY Laboratory, US).
MTT assay
MIN6 cells were seeded at 4×105 cells/well and ARIP cells were seeded at 3×105 cells/well in
six well plates and incubated overnight at 5% CO2, at 37˚C. Following specific experimental
conditions, media was removed and cells were washed with phosphate buffered saline (PBS).
1ml of 0.5mg/ml MTT (3-(4, 5-dimethyl-2-thiazol)-2, 5-diphenyl-2H-tetrazolium bromide)
(Cat No M5655) solution was added to each well and incubated for 1 hour. The MTT solution
was then aspirated and 1ml DMSO (dimethyl sulfoxide) (Cat No 472301) solution added to
each well for 5 minutes to dissolve the crystals. A 200μl sample from each well was transferred
to a 96-well plate and absorbance was read at 540 nm using Multiscan Plate Reader (Thermo
Fisher Scientific, UK). A DMSO alone sample was also analysed to provide a background con-
trol reading.
Hoechst propidium iodide (HPI) staining
MIN6 cells were seeded at 4×105 cells/well and ARIP cells were seeded at 3×105 cells/well in
six well plates and incubated overnight under standard culture conditions. Following specific
experimental conditions, media was removed and cells were washed with PBS. HPI staining
mixture was prepared in culture medium by mixing Hoechst (5mg/ml)/ Propidium iodide
(1mg/ml) and 200μl was added to each well. Hoechst (Cat No B1155), propidium iodide (Cat
No P4864). Cells were analysed by fluorescence microscopy (Zeiss, Axiovert 25) and images
were captured at 10X magnification.
PDCD4 in hypoxia
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Western blotting
MIN6 (4×105 cells/ml) and ARIP (3×105 cells/ml) cells were seeded at in T75 flask and incu-
bated overnight under standard culture conditions. Following specific experimental condi-
tions, media was removed and cells were washed with PBS. Nuclear and cytoplasmic extracts
were prepared as follows: Cells were scraped from the base of the T75 flask and pelleted by cen-
trifugation for 5 minutes. The supernatant was removed and the pellet re-suspended in 200μl
buffer A (10mM HEPES pH 7.9; 10mM KCl, 0.1mM EDTA pH 8.0, EGTA pH 8.0, 1mM DTT,
1 X protease inhibitor cocktail in water) (Protease inhibitor cocktail, Pierce, Thermo Fisher
Scientific, UK, Cat No 88266) and incubated on ice for 15 minutes. For cytoplasmic extracts:
12.5μl of 10% NP-40 added to buffer A and solution vortexed for 30 seconds. Cells were then
centrifuged for 45 seconds. Supernatant was removed and snap frozen in liquid nitrogen. For
nuclear extracts: Following cytoplasmic extraction, the pellet was re-suspended in 50μl buffer
C (20mM HEPES pH 7.9; 400mM NaCl, 1mM EDTA pH 8.0, 1mM EGTA pH 8.0, 1mM DTT,
5% glycerol, 1 X protease inhibitor cocktail in water) and incubated with shaking for 1 hour at
4˚C. Cells were centrifuged for 30 seconds and supernatant was removed and snap frozen in
liquid nitrogen. Protein concentration was determined using Bio-Rad protein Assay Kit
reagent (Biorad, Hemel Hempstead, UK) (Cat No 500–0006). 10μg of protein extracts were
mixed (1:1 ratio) with SDS sample buffer (20% SDS; 0.1% of bromophenol blue; 1.25M
sucrose; 1M Tris-HCl pH 6.8; 10% β-Mercaptoethanol), resolved at 10% SDS-PAGE and sub-
sequently transferred to a nitrocellulose membrane (Amersham Biosciences, UK) (Cat No
28906837). Membranes were blocked using Tris-buffered saline with tween 20 (TBST) con-
taining 10% skimmed dried milk and subsequently probed using Anti-PDCD4 (1:1000), Anti-
β-actin (1:2000) and Anti-Lamin B1 (1:2000) antibodies. After washing, the membrane was
incubated with HRP-conjugated secondary anti-rabbit or anti-mouse antibody and developed
using an ECL-plus (enhanced chemiuminescence) detection kit (Pierce, Thermo Fisher Scien-
tific, UK) (Cat No 80196). Densitometry analyses were performed using the Image J analysis
system (ImageJ.nih.gov).
Immunocytochemistry (ICC)
Subcellular localisation of PDCD4 was assessed by immunocytochemical staining. MIN6 cells
were seeded at 4×105 cells/well and ARIP cells were seeded at 3×105 cells/well on sterile cover
slips in six well plates and incubated overnight under standard culture conditions. Following
specific experimental conditions, media was removed and cells were washed with PBS and
fixed in 3.7% formalin in PBS for 10 minutes. Cells were then permeabilised with 0.1% triton
X-100 in PBS followed by blocking in blocking buffer (10% Goat serum; 2% BSA; 0.2% Tween
20; 0.7% Glycerol in PBS) for 1 hour. Cells were incubated overnight with Anti-PDCD4 anti-
body (1:100) and FITC conjugated secondary anti-rabbit antibody (1:80) was applied. Cover-
slips with stained cells were mounted on glass slides using mounting medium containing
DAPI (Vector laboratories, UK). Cells were finally analysed by confocal microscopy (Leica
TCS SP5, Leica Microsystems, UK) and images were captured under oil immersion at 63X
magnification.
Statistics and densitometry
The data are expressed as mean ± SEM of at least three independent experiments. Statistical
analyses were carried out the using 2-way ANOVA test and significance was determined at p-
values of<0.05 (), <0.01() and<0.001().
PDCD4 in hypoxia
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Results and discussion
Effect of hypoxia on pancreatic cell proliferation
To evaluate the effect of hypoxia on pancreatic cell proliferation, ARIP and MIN6 cells were
exposed to hypoxia for 12 or 24 hours. After treatment, cell viability was determined by MTT
assay and HPI staining. The viability of ARIP cells assessed by MTT assay showed that there
was no significant difference in cell viability between hypoxic and normoxic conditions at all
time points (p>0.05) (Fig 1(A)). However, assessment of viability of ARIP cells by HPI stain-
ing revealed that hypoxia induced apoptosis with substantial numbers of apoptotic cells dem-
onstrating bright blue nuclear staining (Fig 1(B)). Exposure of β-cells to hypoxia revealed not
only a detrimental effect on the viability of MIN6 cells but also significant growth difference
between hypoxic and normoxic conditions at 12 hour (p<0.001) as well as 24 hour (p<0.001)
time points (Fig 1(C)). HPI staining indicated that hypoxia induced both apoptosis and necro-
sis in MIN6 cells with both bright blue/red nucleus observed (Fig 1(D)). Overall, results indi-
cate that hypoxia has a detrimental effect on the viability of pancreatic β-cells and induces
Fig 1. Effect of hypoxia on cell viability of ARIP and MIN6 cells analysed by MTT assay and HPI staining. (A) ARIP cells were
exposed to hypoxia and no significant difference in viability was observed between hypoxic and normoxic conditions at 12 or 24 hour time
points (p>0.05), error bar values represent mean +/- standard error. (B) Bright blue nuclei were observed indicating apoptosis triggered by
hypoxia in ARIP cells. (C) In MIN6 cells, significant differences in viability between hypoxic and normoxic conditions at 12 hour (***
p<0.001) as well as 24 hour (*** p<0.001) time points were observed; error bar values represent mean +/- standard error. (D) Bright blue
and red coloured nuclei were observed indicating apoptosis and necrosis triggered by hypoxia in MIN6 cells. (Scale bars = 300 μm).
https://doi.org/10.1371/journal.pone.0181235.g001
PDCD4 in hypoxia
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apoptosis in pancreatic cells. These results were additionally confirmed by scanning electron
microscopy analysis (S1 Fig).
Effect of hypoxia on PDCD4 expression
Our previous studies have identified the upregulation of Pdcd4 both during the process of in
vivo islet neogenesis and in vitro with PDCD4 expression observed in both beta cell and ductal
cell lines [12]. We have therefore further examined the effect of hypoxia on PDCD4 expres-
sion. Western blotting (WB) was performed to investigate the expression of PDCD4 in ARIP
and MIN6 cells in response to hypoxia and normoxia. Nuclear and cytoplasmic protein lysates
of ARIP cells were subjected to WB and showed that PDCD4 was highly expressed in the cyto-
plasm compared to the nucleus of the cell (Fig 2). Densitometry analysis indicated that hypoxia
induced expression of PDCD4 in the cytoplasm. Expression of PDCD4 was significantly
higher in hypoxic conditions after 24 hours (p<0.01) and significantly lower in normoxic con-
ditions after 12 hours (p<0.01) compared to basal level. WB results in MIN6 cells confirmed
that hypoxia induced the expression of PDCD4 and that it was highly expressed in the cyto-
plasm compared to the nucleus of the cell (Fig 3). Densitometry analysis of MIN6 cells
Fig 2. Hypoxia induced the expression of PDCD4 in ARIP cells. ARIP cells were cultured under serum starvation
conditions (G0), normoxic or hypoxic conditions for 12 or 24 hours as indicated. Cytoplasmic and nuclear proteins were
prepared and analysed by western blotting using an antibody specific to PDCD4. Panel A (I) represents PDCD4 (52kDa)
protein expression in the cytoplasm (II) represents protein loading control β-actin (42kDa). Panel B (I) represents PDCD4
(52kDa) protein expression in the nucleus (II) represents protein loading control lamin B1 (74kDa). Panel C illustrates
densitometry analyses, showing cytoplasmic PDCD4 relative to β-actin and nuclear PDCD4 relative to lamin B1. These
results were reproduced in at least three separate experiments. Error bar values represent mean +/- standard error.
**p<0.01 comparing the samples indicated.
https://doi.org/10.1371/journal.pone.0181235.g002
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confirmed that expression of PDCD4 was significantly higher in hypoxic conditions after 24
hours (p<0.001) compared with all time points. In addition, densitometry also showed that
there was no significant difference in expression of PDCD4 in ARIP cells under hypoxic and
normoxic conditions (p>0.05). However, PDCD4 expression in MIN6 cells maintained under
hypoxic conditions was significantly higher (p<0.001) compared to cells in normoxic condi-
tions. Overall these results indicate that the increased expression of PDCD4 observed in MIN6
cells in hypoxic conditions may be a factor leading to β-cell death demonstrated in the viability
studies.
Cellular localisation of PDCD4 in pancreatic cells
There is conflicting data on the subcellular localisation of PDCD4 expression [12, 31, 32] and
how it exerts its activity [30]. We have investigated the subcellular localisation of PDCD4 in
pancreatic cells maintained in normoxic and hypoxic conditions. Immunocytochemistry anal-
ysis of PDCD4 in ARIP cells showed that PDCD4 was highly expressed in the cytoplasm com-
pared to the nucleus of the cells (Fig 4). In addition, weak expression of PDCD4 was observed
in ARIP cells under conditions of serum starvation, hypoxia (12 hours) and normoxia (12
hours) although, strong PDCD4 expression was observed after 24 hours in both hypoxia and
normoxia (Fig 4). In MIN6 cells PDCD4 was highly expressed in the cytoplasm compared to
the nucleus under all conditions (Fig 4). In hypoxia (24 hours), PDCD4 was exclusively
expressed in the cytoplasm (Fig 5). ICC findings also suggested that PDCD4 expression was
localised to the cytoplasm, with no shuttling between the cytoplasm and the nucleus or vice
Fig 3. Hypoxia induced the expression of PDCD4 in MIN6 beta cells. MIN6 cells were cultured under serum starvation conditions (G0),
normoxic and hypoxic conditions for 12 or 24 hours. Cytoplasmic and nuclear proteins were prepared and analysed by western blotting
using an antibody specific to PDCD4. Panel A (I) represents PDCD4 (52kDa) protein expression in the cytoplasm (II) represents protein
loading control β-actin (42kDa). Panel B (I) Represents PDCD4 (52kDa) protein expression in the nucleus (II) represents protein loading
control lamin B1 (74kDa). Panel C illustrates densitometry analysis, showing cytoplasmic PDCD4 relative to β-actin and nuclear PDCD4
relative to lamin B1. These results were reproduced in at least three separate experiments. Error bar values represent mean +/- standard
error. ***p<0.001, *p<0.05 comparing the sample indicated.
https://doi.org/10.1371/journal.pone.0181235.g003
PDCD4 in hypoxia
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versa under any of the conditions studied. To additionally confirm the accuracy and specificity
of our western blot nuclear/cytoplasmic fractionation and the accuracy of our ICC staining
protocols, the same analyses were performed for transcription factor HIF-1α (S2 and S3 Figs),
which was demonstrated to localise specifically to the nucleus, with no detectable cytoplasmic
staining.
The tumour suppressor PDCD4 has been linked to T1D [11], obesity linked diseases [37]
and our previous studies have reported the role of Pdcd4 in pancreatic islet neogenesis [12].
The exact role of PDCD4 during the process of apoptosis remains to be clarified, as some stud-
ies have identified it as being up-regulated [13] and others as down-regulated [38]. The current
findings have indicated that PDCD4 is upregulated during the process of apoptosis in pancre-
atic cells exposed to periods of hypoxia.
Fig 4. Sub-cellular localisation and expression of PDCD4 in ARIP ductal cells. Immunocytochemistry was performed using a specific
antibody to PDCD4 and FITC labelled secondary antibody was used. Coverslips with cells were mounted on glass slides with mounting
medium containing DAPI (Blue) which stains the nucleus of the cells. Cells were analysed by confocal microscopy and images were
captured at 63X magnification. Results are representative of three separate experiments and images were representative of six separate
fields. PDCD4 localized and expressing At G0: Cytoplasmic and very low expression; At N12: Cytoplasmic and low expression; At N24: very
high cytoplasmic and low nuclear expression; At H12: Cytoplasmic expression and At H24 very high cytoplasmic and low nuclear
expression. Over-all PDCD4 was highly expressed in the cytoplasm, with very low expression under serum starved conditions. (Scale
bars = 25 μm).
https://doi.org/10.1371/journal.pone.0181235.g004
PDCD4 in hypoxia
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In the present investigation we have attempted to define the mechanism of pancreatic cell
death in response to hypoxia. Many studies have reported that pancreatic beta cell lines are
sensitive to hypoxia because of the high rate of mitochondrial respiration required to support
insulin secretion [5]. Our viability analyses confirmed that MIN6 cells are highly sensitive to
hypoxia, since under hypoxic conditions a massive loss of cell population occurs, reaching
approximately 70% in 24 hours following induction of apoptosis as well as necrosis (Fig 1).
The MTT results for ARIP cells showed no effect of hypoxia on growth, whereas HPI stain-
ing indicated that hypoxia triggered apoptosis following 24 hours of hypoxia. A potential
explanation for the differing results obtained using the MTT and HPI assays in hypoxia might
Fig 5. Sub-cellular localisation and expression of PDCD4 in MIN6 beta cells. MIN6 cells were grown on glass cover slips in six well
plates and fixed at various time points i.e. at G0 (serum starvation), N12 & N24 (normoxic) and H12 & H24 (hypoxic). Immunocytochemistry
was performed using a specific antibody to PDCD4 and FITC labelled secondary antibody was used. Coverslips with cells were mounted on
glass slides with mounting medium containing DAPI (Blue) which stains the nucleus of the cells. Cells were analysed by confocal
microscopy and images were captured at 63X magnification. Results are representative of three separate experiments and images were
representative of six separate fields. PDCD4 localized and expressed at G0, N12, N24 and H12: Cytoplasmic and very low nuclear
expression; At H24: High cytoplasmic expression. Overall, PDCD4 was highly expressed in the cytoplasm, with very low nuclear expression.
(Scale bars = 25 μm).
https://doi.org/10.1371/journal.pone.0181235.g005
PDCD4 in hypoxia
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be that ARIP cells were in the early phase of apoptosis, as the early phase of apoptosis does not
affect membrane permeability, or cause any alteration in the activity of mitochondria. There-
fore, the MTT assay might be more effective for detecting the later stages of apoptosis [39, 40].
Thus MTT assay may therefore underestimate the levels of apoptosis if the apoptosis process is
at an early stage. Also when comparing the viability of ARIP and MIN6 cells after exposure to
hypoxic conditions we demonstrated detrimental effects on beta cell growth and viability, but
this again was not observed in pancreatic ductal cells. These observations may have great rele-
vance to the damaging processes experienced by β-cells during the procedure of islet isolation
and transplantation [41, 42]. Hypoxia is an inevitable result of the devascularisation which
occurs during islet isolation and purification; the subsequent transplantation into an environ-
ment without an oxygen supply ultimately results in a negative impact on beta-cell survival
[43]. It is believed that after islet transplantation, revascularization of pancreatic islets may
take several days [44] and β-cells will therefore experience hypoxia which may have a detri-
mental effect on β-cell function [43, 45, 46]. Revascularization and supply of sufficient oxygen
to pancreatic islets can provide protection against hypoxia and ultimately can increase β-cells
survival [46]. Our observations of β-cell viability support this need to maintain oxygen supply
for beta cell survival, which could have a positive impact on islet transplantation procedures.
The possible involvement of PDCD4 in apoptosis has been reported in many studies and
loss of its expression has been observed in many cancers, which makes PDCD4 a potential
therapeutic target. Recently, it has been reported that hypoxia induces tumour cell resistance
to apoptosis and results in decreased response to chemotherapy by up regulating miR-424
which in turn supresses the level of PDCD4 protein in A375 tumour cells [47]. Our results
clearly indicated that hypoxia significantly induced the expression of PDCD4 in both ARIP
and MIN6 cells. Pancreatic cell viability and PDCD4 western blotting analyses suggested that
PDCD4 might play role in the induction of apoptosis in pancreatic cells. However, high
expression of PDCD4 was observed in ductal and β-cells (ARIP and MIN6) following sus-
tained hypoxia (24 hours) but was not detected in individual populations of apoptotic or
necrotic cells. Thus, the present data suggests that there may be a link between high levels of
PDCD4 expression and apoptosis or necrosis induced under hypoxic conditions in ARIP and
MIN6 cells.
To attempt to answer the question of whether higher expression of PDCD4 in hypoxia
induces apoptosis in pancreatic cells, we sought to determine if it is indeed only increased
PDCD4 expression that induces the apoptosis or whether the subcellular localisation of
PDCD4 also plays a role in its activity. How PDCD4 exerts its effects is still not clear, but it has
been reported that in the cytoplasm, PDCD4 inhibits helicase activity of eIF4a as well as inter-
fering with the interaction of eIF4a with eIF4G, ultimately resulting in an inhibitory effect on
protein translation [29, 30]. Studies of the role of PDCD4 in apoptosis have also provided
inconsistent findings; PDCD4 has a role in apoptosis in the case of lung [48] and breast cancer
[49] however, no apoptotic effect has been found in other tissues [50, 51]. It is worth noting
that in other cell types, PDCD4 has been implicated in a broad range of cellular processes, act-
ing as a tumour suppressor through several alternative mechanistic pathways [52, 53]. Indeed
even within pancreatic tissue we have previously shown that PDCD4 is linked to islet neogen-
esis in vivo, being expressed in both islet cells and pancreatic ductal cells [12]. Previous studies
have suggested a potentially cell type specific role for PDCD4 [34]. It is certainly possible that
PDCD4 plays more than one role within individual pancreatic cell types. Our data from
immunocytochemistry analyses have shown that PDCD4 was mostly localised in the cyto-
plasm of pancreatic cell lines (ARIP and MIN6 cells) with no observed translocation or shut-
tling of PDCD4 between the cytoplasm and the nucleus, thereby complimenting the parallel
western blotting findings.
PDCD4 in hypoxia
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Briefly, our data demonstrated that hypoxia induced expression of PDCD4 may be linked
to the induction of apoptosis in both of the pancreatic cell lines studied. A summary of our
proposed model is shown in Fig 6. These studies open up the exciting possibility that PDCD4
could provide a new potential molecular target in the therapy of T1D.
Supporting information
S1 Fig. Scanning electron microscopy of the surface morphology of mouse pancreatic beta
cells (MIN6). MIN6 cells were fixed with 2.5% glutaraldehyde and coated with platinum
coating (4nm). Cells were examined using Zeiss Sigma field emission gun SEM (Zeiss NTS).
Images were captured at magnifications 1K (A-E), 10K (F-J) and 50K (K-O). Images were
representative of six separate fields. At G0 (A, F & K), N12 (B, G & L) & N24 (C, H & M)
cells grew in groups and formed tight intercellular (cell to cell) contacts. Under hypoxic condi-
tions at 12 hours (D, I & N) cell numbers fell and blebbing of the plasma membrane was
observed, indicating apoptosis (highlighted by arrows). Under hypoxic conditions at 24 hours
(E, J & O), a very low population of cells was observed and plasma membrane pores indicative
of necrosis were observed (highlighted by arrows). Scale bars for A-E = 10μm, F-J = 1μm and
K-O = 200nm.
(TIF)
Fig 6. Schematic representation of the proposed effect of PDCD4 expression on cell survival in the pancreas. In this
study, we have explored the role of hypoxia in controlling expression of PDCD4. Hypoxia (1% oxygen) induces the
expression of PDCD4 in pancreatic cells such as MIN6 and ARIP cells, resulting in low proliferation and the triggering of
apoptosis, whereas under normoxic conditions (21% oxygen) expression of PDCD4 stayed low resulting in cell proliferation
and survival. The role of PDCD4 under hypoxic conditions may well be decided by the master regulator of oxygen
homeostasis, HIF-1α.
https://doi.org/10.1371/journal.pone.0181235.g006
PDCD4 in hypoxia
PLOS ONE | https://doi.org/10.1371/journal.pone.0181235 July 27, 2017 11 / 15
S2 Fig. Subcellular localisation of HIF-1α in pancreatic ductal cells. ARIP cells were cul-
tured under G0 (serum starvation), normoxic or hypoxic conditions for 12 or 24 hours. After
each indicated incubation period, the cells were pelleted. Cytoplasmic and nuclear proteins
were extracted and 10μg of cytoplasmic and nuclear cell extract were separated on a 10%
SDS-PAGE. Proteins were western blotted using an antibody specific to HIF-1α. Panel A (I)
represents HIF-1α (102kDa) protein expression in the cytoplasm (II) represents protein load-
ing control β-Actin (42kDa). Panel B (I) represents HIF-1α (102kDa) protein expression in the
nucleus (II) represents protein loading control lamin B1 (74kDa). Panel C illustrates densitom-
etry analysis showing cytoplasmic HIF-1α relative to control β-Actin and nuclear HIF-1α rela-
tive to lamin B1. These results were reproduced in at least three separate experiments. Error
bar values represent mean +/- standard error. HIF-1α was exclusively expressed in the nucleus
under normoxic and hypoxic conditions. Expression of HIF-1α was significantly higher at
H24 (p<0.001) compared to G0. Also HIF-1α was significantly higher at H24 (p<0.01)
compared to N24.
(TIF)
S3 Fig. Sub-cellular localisation and expression of HIF-1α in pancreatic ductal cells. ARIP
cells were grown on glass cover slips in six well plates and fixed at specific time points i.e. at G0
(Serum starvation), N12 & N24 (Normoxic) and H12 & H24 (Hypoxic). Immunocytochemis-
try was performed using a specific antibody to HIF-1α and a FITC labelled secondary anti-
body. Coverslips with cells were mounted on glass slides with mounting medium containing
DAPI which stains the nucleus of cells. Cells were analysed by confocal microscopy and images
were captured at 65X magnification. Results are representative of three separate experiments
and images were represented in six separate fields. HIF-1α was exclusively localized and
expressed in the nucleus of ARIP cells. In addition, expression of HIF-1α was increased at H24
compared to G0.
(TIF)
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